Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02961894 · ClinicalTrials.gov registry record · NA
Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization
A NA study, sponsored by Rex Medical.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT02961894 is a NA study that has completed, run by Rex Medical. The registered enrollment target is 121 participants.
The verdict
NCT02961894, a NA study, has completed, sponsored by Rex Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of the Revolution™ Peripheral Atherectomy System in the treatment of infrainguinal lower extremity peripheral arterial occlusive disease. This Atherectomy system will be used on eligible patients with stenosis of at least 70% diameter reduction to evaluate the change in stenosis after the procedure (effectiveness) and the presence of any major adverse events (safety) for up to 30 days after the procedure.
Interventions
- DEVICE Revolution™ Peripheral Atherectomy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2017-06-07 |
| Est. Completion | 2019-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02961894
The ClinicalTrials.gov registry entry for NCT02961894 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rex Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Revolution™ Peripheral Atherectomy System is the first listed.
NCT02961894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02961894 about?
NCT02961894 is a clinical study titled "Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization". To evaluate the safety and effectiveness of the Revolution™ Peripheral Atherectomy System in the treatment of infrainguinal lower extremity peripheral arterial occlusive disease. This Atherectomy system will be used on eligible patients with stenosis of at least 70% diameter reduction to evaluate t...
What is the current status of trial NCT02961894?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2017-06-07. Estimated completion is 2019-09-20.
What interventions are being tested in trial NCT02961894?
The interventions under investigation include: Revolution™ Peripheral Atherectomy System (DEVICE).
Who is sponsoring clinical trial NCT02961894?
This trial is sponsored by Rex Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.